]>
IRCT20220131053899N1 IRCT 2022-05-14 Tehran University of Medical Sciences Formulation and standardization of Yazd Meybod ethno-topical preparation made from cotton (Gossypium herbaceum L.) to evaluate the effect on cutaneous Leishmaniasis, a randomized, double blind, placebo controlled trial. Formulation and standardization of Yazd Meybod ethno-topical preparation made from cotton (Gossypium herbaceum L.) to evaluate the effect on cutaneous Leishmaniasis, a randomized, double blind, placebo controlled trial. 2022-05-22 anticipated 70 Complete https://irct.ir/trial/61689 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: using random number table, Blinding description: This study is a single centered, double-blinded, placebo-controlled, randomized clinical trial which is a medical study involving human participants in which neither side knows who's getting the true remedy or placebo that subjects are randomly assigned to by random number table. There are two groups contaminated with cutaneous leishmaniasis that are matched by age and sex. The assessors also do not know what medication the patient has received. 3 cutaneous leishmaniasis. Intervention 1: Each patient receives one milliliter of medication per square centimeter of lesion multiplication on treatment days plus a bandage to cover the lesion and prevent loss of topical medication. Patients take the drug for 30 days and should visit on days 5, 10, 20 and 30 and their wounds should be evaluated. Intervention 2: Control group: Recipients of topical placebo. Yes - There is a plan to make this available What will be shared: Publishing in an qualified journal When: in years 2023 to 2024 To whom: Public Conditions: referencing Where to obtain: Ali Mohammad Mosadegh How to obtain: Official Comments:
public Ali Mohammad Mosadegh
No 27, Sarparast Ave, Taleghani Street, Palestine Square
Tehran Iran (Islamic Republic of) 1417613151 +98 21 8897 6527 ali.moh.mosadegh@gmail.com Tehran University of Medical Sciences scientific Arman Zargaran
No 27, Sarparast Ave, Taleghani street, Palestine Square, Tehran
Tehran Iran (Islamic Republic of) 1417613151 +98 21 8897 6530 arman_zargaran@yahoo.com Tehran University of Medical Sciences Iran (Islamic Republic of) Cannot be using any kind of therapy for leishmaniasis No lesions with a diameter bigger than 3 centimeters Have no kind of immune deficiency diseases No lesions located on the face or joints and have less than 5 lesions Patients with less than 5 ulcers no limit no limit Both Any severe side effects or allergies Patients that do not apply the remedy daily or perform the protocol correctly B55.1 Cutaneous leishmaniasis Treatment - Drugs Placebo Each patient receives one milliliter of medication per square centimeter of lesion multiplication on treatment days plus a bandage to cover the lesion and prevent loss of topical medication. Patients take the drug for 30 days and should visit on days 5, 10, 20 and 30 and their wounds should be evaluated. Control group: Recipients of topical placebo Ulcer diameter. Timepoint: 30 days after starting treatment. Method of measurement: caliper. Tehran University of Medical Sciences Approved 2022-03-13 Ethics committee of Tehran university of medical sciences Ghods street, Keshavarz Blvd Tehran Tehran Iran (Islamic Republic of)